Probably Genetic

Probably Genetic’s builds highly specific and efficient patient recruiting pipelines for biotech companies by identifying patients with super-rare diseases.

A direct-to consumer DNA test to help identify super-rare disease patients


400+ million people worldwide are suffering from rare genetic conditions but only 5% of known rare diseases have FDA approved medication available. Biotech companies are struggling to find treatments because of the complexities related to identifying patients for their clinical studies. The rarer a disease, the harder it is to do research on it and find a cure.


Probably Genetic combines genetic science and a sophisticated toolkit of NLP-assisted online marketing methods to find and assess potential rare disease patients. Clinical-grade, fast and affordable DNA tests help identify the right patients, who can then be referred to clinical studies. This benefits individuals as well the biotech companies conducting research.

Team members
  • Lukas Lange
  • Harley Katz
Investment manager
Digital Health
Year invested

More Use Cases

We are a fund built
by founders for founders

Successful founders supporting new founders in a way not yet seen in European venture capital. Let us be part of your journey!

Submit your pitch